
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.730 | 5.730 | 0.000 |
Shares | 94.270 | 94.270 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.886 | 20.853 |
Price to Book | 5.355 | 3.544 |
Price to Sales | 3.622 | 3.087 |
Price to Cash Flow | 15.681 | 13.734 |
Dividend Yield | 2.376 | 2.082 |
5 Years Earnings Growth | 9.739 | 12.215 |
Number of long holdings: 31
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.61 | 732.58 | +0.08% | |
J&J | US4781601046 | 6.91 | 177.17 | +0.98% | |
Thermo Fisher Scientific | US8835561023 | 6.29 | 492.72 | +0.61% | |
AbbVie | US00287Y1091 | 6.17 | 210.40 | +1.19% | |
UnitedHealth | US91324P1021 | 6.12 | 309.87 | +2.51% | |
Intuitive Surgical | US46120E6023 | 5.11 | 473.30 | -0.11% | |
Roche Holding Participation | CH0012032048 | 5.00 | 260.20 | -0.04% | |
Novo Nordisk B | DK0062498333 | 4.94 | 365.1 | +1.76% | |
Merck&Co | US58933Y1055 | 4.72 | 84.12 | +1.09% | |
Novartis | CH0012005267 | 4.49 | 101.54 | +0.38% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JP90C0009VE0 | 865.72B | 3.86 | 20.96 | 13.18 | ||
JP90C000PDY6 | 341.8B | 2.94 | - | - | ||
Nissay Nikkei 225 Index Fund | 305.65B | 3.88 | 15.85 | 8.94 | ||
Nissay DC Nissay Foreign Equity | 250.56B | 3.86 | 20.94 | 13.16 | ||
Nissay Japan Equity Fund | 183.94B | 5.84 | 16.98 | 7.02 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review